1/ I am so relieved to hear this news:
The U.S. has identified sources of specific raw material urgently required for Indian manufacture of the Covishield vaccine that will immediately be made available for India.
whitehouse.gov/briefing-room/…
The U.S. has identified sources of specific raw material urgently required for Indian manufacture of the Covishield vaccine that will immediately be made available for India.
whitehouse.gov/briefing-room/…
2/ To help treat COVID patients and protect front-line health workers in India, the United States has identified supplies of therapeutics, rapid diagnostic test kits, ventilators, and PPE that will immediately be made available for India.
3/ The U.S. is pursuing options to provide oxygen generation and related supplies on an urgent basis.
4/ The U.S. Development Finance Corporation is funding a substantial expansion of manufacturing capability for BioE, the vaccine manufacturer in India, enabling BioE to ramp up to produce at least 1 billion doses of COVID-19 vaccines by the end of 2022.
5/ The U.S. is deploying an expert team of public health advisors from @CDCgov and @USAID to work in close collaboration with the U.S. Embassy, India’s health ministries, and India’s Epidemic Intelligence Service staff.
6/ @USAID will also quickly work with @CDCgov to support and fast-track the mobilization of emergency resources available to India through The @GlobalFund.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
